Key result
Intracoronary injection of nitroglycerin decreased diameter stenosis from 66.6% to 58.3% in atherothrombotic culprit lesions of STEMI patients receiving primary PCI.
Why the study?
The vasoconstrictor component of atherothrombotic culprit lesions in STEMI patients had not been fully investigated.
Does intracoronary nitroglycerin injection alter angiographic lesion dimensions in patients with STEMI receiving primary PCI?
Observational (n=100)
Yes
Does intracoronary nitroglycerin injection alter angiographic lesion dimensions in patients with STEMI receiving primary PCI?
Intracoronary nitroglycerin reveals a vasoconstrictor component in STEMI culprit lesions, suggesting its use may help decrease the required stent length during primary PCI.
Answers are grounded in this paper and cite their sources.
May indicate vasoconstrictor component in STEMI lesions; leaves open effect on stent length or outcomes.
OBJECTIVE: The vasoconstrictor component of atherothrombotic culprit lesions in ST-elevation myocardial infarction (STEMI) patients has not been fully investigated. This study was aimed at assessing the vasoconstrictor component of atherothrombotic culprit lesions in patients with STEMI receiving primary percutaneous coronary intervention (PCI). METHODS: A group of 100 patients with STEMI were enrolled prospectively. Baseline coronary angiography achieving normal antegrade flow was followed by 200 μg of intracoronary nitroglycerin (NTG) injection and repeat coronary angiography at the same projection view for culprit lesions was performed. End points were the changes in lesion length, reference vessel diameter, minimal lumen diameter, and diameter stenosis by quantitative coronary analysis before and after NTG injection. CONCLUSION: This study showed the presence of a vasoconstrictor component in atherothrombotic culprit lesions in STEMI patients receiving primary PCI. Vasodilating effort by NTG may decrease stent length used for culprit lesions.
No takes yet. Share an insight, caveat, or question.
Her et al. (2019) conducted an observational in ST-segment elevation myocardial infarction (n=100). Intracoronary nitroglycerin vs. Baseline (before injection) was evaluated on Diameter stenosis (p=<0.001). Intracoronary injection of nitroglycerin decreased diameter stenosis from 66.6% to 58.3% in atherothrombotic culprit lesions of STEMI patients receiving primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: